Your browser doesn't support javascript.
loading
Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study.
Kevorkian, Jean-Philippe; Lopes, Amanda; Sène, Damien; Riveline, Jean-Pierre; Vandiedonck, Claire; Féron, Florine; Nassarmadji, Kladoum; Mouly, Stéphane; Mauvais-Jarvis, Franck; Gautier, Jean-François; Mégarbane, Bruno.
Afiliação
  • Kevorkian JP; Department of Diabetes and Endocrinology, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, 75010, Paris, France. Electronic address: jean-philippe.kevorkian@aphp.fr.
  • Lopes A; Department of Internal Medicine, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, 75010, Paris, France.
  • Sène D; Department of Internal Medicine, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, 75010, Paris, France; INSERM UMRS 976, Institut de Recherche Saint Louis, Université de Paris, 75010, Paris, France.
  • Riveline JP; Department of Diabetes and Endocrinology, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, 75010, Paris, France; Centre de Recherche des Cordeliers, INSERM UMRS-1138, IMMEDIAB Laboratory, Université de Paris, 75006, Paris, France.
  • Vandiedonck C; Centre de Recherche des Cordeliers, INSERM, Université de Paris, IMMEDIAB Laboratory, F-75006, Paris, France.
  • Féron F; Department of Diabetes and Endocrinology, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, 75010, Paris, France.
  • Nassarmadji K; Department of Internal Medicine, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, 75010, Paris, France.
  • Mouly S; Department of Internal Medicine, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, INSERM UMRS-1144, 75010, Paris, France.
  • Mauvais-Jarvis F; Section of Endocrinology and Metabolism, Department of Medicine, Tulane University Health Sciences Campus, New Orleans, LA, United States; Medicine/Endocrine Service, Southeast Louisiana Veterans Health Care System, New Orleans, LA, United States.
  • Gautier JF; Department of Diabetes and Endocrinology, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, 75010, Paris, France; Centre de Recherche des Cordeliers, INSERM UMRS-1138, IMMEDIAB Laboratory, Université de Paris, 75006, Paris, France.
  • Mégarbane B; Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, INSERM UMRS-1144, 75010, Paris, France. Electronic address: Bruno.megarbane@lrb.aphp.fr.
J Infect ; 82(6): 276-316, 2021 06.
Article em En | MEDLINE | ID: mdl-33577902
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Furosemida / COVID-19 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Furosemida / COVID-19 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article